Company Overview of NKT Therapeutics, Inc.
NKT Therapeutics, Inc., a biotechnology company, engages in developing therapeutics based on immune cells called natural killer T cells (NKT). It focuses to develop a pipeline of NKT based therapeutics to treat cancer, infectious diseases, autoimmune diseases, asthma, and atopic dermatitis. The company was incorporated in 2008 and is based in Waltham, Massachusetts.
1000 Winter Street
Waltham, MA 02451
Founded in 2008
Key Executives for NKT Therapeutics, Inc.
NKT Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Oncotide Pharmaceuticals Inc||United States|
|TheraKine Inc.||United States|
|InCytu, Inc.||United States|
|Egenix, Inc.||United States|
|Tyrogenex, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- San Francisco, CA | Investment Firm Providing Private and Institutional BrokeragePosted: Apr 07
- Gaithersburg, MD | MedimmunePosted: Apr 16
- San Mateo, CA |Posted: Apr 05
- New York | Shore ConsultantsPosted: Apr 14
Sponsored Financial Commentaries
To contact NKT Therapeutics, Inc., please visit www.nktrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.